The DOI matches its Crossref record.
Increased incidence of bone metastases in hepatocellular carcinoma
Abstract
OBJECTIVES: Recently, we often encounter hepatocellular carcinoma patients with bone metastases. We therefore examined the changes in the incidence of bone metastases in hepatocellular carcinoma from 1978 to 1997 and tried to identify the characteristic clinical features. We also discuss the reasons for the increased incidence of bone metastasis in hepatocellular carcinoma. METHODS: A total of 673 patients with hepatocellular carcinoma during the period 1978-1997 were studied. Bone metastasis was screened by bone scintigraphy, and bone lesions were confirmed by plain radiography, computed tomography and/or magnetic resonance imaging. The serum levels of the C-terminal telopeptide of type 1 collagen, which represent osteoclastic bone resorption, were also measured. RESULTS: The incidence of bone metastasis during the decade 1988-1997 was significantly higher than that during the period 1978-1987. The median survival time of patients with hepatocellular carcinoma during 1988-1997 was also significantly longer than that during 1978-1987. Portal thrombus was found in about half of the patients with bone metastases. The most common site of bone metastases was the vertebra followed by the pelvis, rib and skull in that order. All bone lesions depicted by plain radiograph, computed tomography and/or magnetic resonance imaging were of the osteolytic type, and the serum levels of C-terminal telopeptide of type 1 collagen were significantly elevated in the patients with bone metastases. CONCLUSIONS: The increased incidence of bone metastasis in hepatocellular carcinoma in the decade 1988-1997 is first attributed to the prolonged survival rate of hepatocellular carcinoma patients due to recent progress in both the diagnosis and treatment of the disease. Dissemination of hepatocellular carcinoma cells to the vertebra through the portal vein-vertebral vein plexuses due to the presence of portal thrombus and/or portal hypertension may be related to a higher incidence of bone metastasis in hepatocellular carcinoma. Both an early diagnosis and timely treatment of bone metastases are thus called for in the follow-up of hepatocellular carcinoma patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Cancer to bone: a fatal attraction
Weilbaecher, K. N., Guise, T. A., & McCauley, L. K. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3055 · Cited by 1,285
Clinical features of hepatocellular carcinoma with extrahepatic metastases
NATSUIZAKA, M., OMURA, T., AKAIKE, T., KUWATA, Y., YAMAZAKI, K., SATO, T., KARINO, Y., TOYOTA, J., SUGA, T., & ASAKA, M. (2005) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.03919.x · Cited by 527
N6-Methyladenosine Modification of ANLN Enhances Hepatocellular Carcinoma Bone Metastasis
Zheng, H., Cheng, Z.-J., Liang, B., Wang, Z.-G., Tao, Y.-P., Huang, S.-Y., Ni, J.-S., Li, H.-F., Yang, L., Yuan, S.-X., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.73570 · Cited by 33
Bone metastases from hepatocellular carcinoma: clinical features and prognostic factors
Lu, Y., Hu, J.-G., Lin, X.-J., & Li, X.-G. (2017) · Hepatobiliary & Pancreatic Diseases International · doi:10.1016/s1499-3872(16)60173-x · Cited by 26
Metadata
- Authors
- Fukutomi, M., Yokota, M., Chuman, H., Harada, H., Zaitsu, Y., Funakoshi, A., Wakasugi, H., & Iguchi, H.
- Venue
- European Journal of Gastroenterology & Hepatology
- Published
- 2001-09
- Volume
- 13
- Issue
- 9
- Pages
- 1083-1088
- ISSN
- 0954-691X (ISSN-L)
- OpenAlex
- W2068836262
- Cited by
- 211
- References
- 0
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increased incidence of bone metastases in hepatocellular carcinoma. https://app.cochat.ai/papers/10.1097/00042737-200109000-00015
- The paper
- Fukutomi, M., Yokota, M., Chuman, H., Harada, H., Zaitsu, Y., Funakoshi, A., Wakasugi, H., & Iguchi, H. (2001). Increased incidence of bone metastases in hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology. https://doi.org/10.1097/00042737-200109000-00015
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.